All Type of News
Concerns mounting over cash incentive plan
It has long been a tough challenge for health authorities to break corrupt ties between drug makers, doctors and pharmacists. There are still many medical professionals who do not feel compunction about taking rebates...
Health insurance premium to rise 5.6%
The national health insurance premium will go up by an average of 5.6 percent for salaried workers from next year, the Ministry for Health and Welfare said Tuesday.
According to the health ministry, the monthly pr...
Medical bills for osteoporosis patients will go down
The costs that individuals will have to shoulder for treatment of osteoporosis will go down thanks to the government’s plan to give more benefits to subscribers, according to the Ministry of Health and Welfare.
Und...
GSK’s Avandia monthly sales slide to 6 million won
GlaxoSmithKline’s embattled diabetes drug Avandia has lost a lot of market ground in the market to competitors as a medicine for type 2 diabetes, even if the Korea Food and Drug Administration (KFDA) ordered doctors t...
Domestic drugmakers to sign MOU with wholesalers
The Korea Pharmaceutical Manufacturers Association has unveiled its plan to strengthen its ties with pharmaceutical wholesalers ahead of the lifting of controversial unified distribution system at the end of this mont...
Doctor group denounces DTC prescription ads plan
Controversy is escalating over the Korea Communications Commission (KCC)’s plan to allow the direct-to-consumer (DTC) ads for prescription drugs next year.
In its briefing to President Lee Myung-bak on Friday, the ...
Glucosamine sulfate is effective for treatment of osteoarthritis, KFDA says
The controversial dietary supplement, glucosamine, or Glucosamine sulfate, is useful in treatment of mild to moderate osteoarthritis, according to the Korea Food and Drug Administration.
The drug agency recommended...
Doctors drop accusation
The National Union of Korean Medical Doctors says it decided to withdraw an accusation against Hanmi Pharmaceutical for having provided illegal kickbacks to doctors.
The withdrawal decision came as Hanmi expressed ...
Zuellig Pharma to focus on distribution of vaccines
Zuellig Pharma, a regional distributor of pharmaceutical and health care products, said Tuesday that it will concentrate on distributing more high-priced drugs, such as vaccines and antibiotics, in the domestic logist...
Plavix combination drug market emerging as blue chip
Many major Korea pharmaceutical manufacturers are poised to introduce a combination product of Plavix and Aspirin (clopidogrel + acetylsalicylate 75 mg) with the hope of acquiring large share of the blockbuster drug a...
